Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging

Injection of tissues with senescent cells induces changes that mimic aging, and this process is delayed in mice engineered to eliminate senescent cells, which secrete proinflammatory cytokines, including C-C motif chemokine ligand 2 ( ). Circulating levels of correlate with age, but the impact of on...

Full description

Saved in:
Bibliographic Details
Published inAging (Albany, NY.) Vol. 12; no. 20; pp. 20001 - 20023
Main Authors Luciano-Mateo, Fedra, Cabré, Noemí, Baiges-Gaya, Gerard, Fernández-Arroyo, Salvador, Hernández-Aguilera, Anna, Elisabet Rodríguez-Tomàs, Elisabet, Arenas, Meritxell, Camps, Jordi, Menéndez, Javier A, Joven, Jorge
Format Journal Article
LanguageEnglish
Published United States Impact Journals 26.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Injection of tissues with senescent cells induces changes that mimic aging, and this process is delayed in mice engineered to eliminate senescent cells, which secrete proinflammatory cytokines, including C-C motif chemokine ligand 2 ( ). Circulating levels of correlate with age, but the impact of on tissue homeostasis has not been established. We generated an experimental model by crossbreeding mice overexpressing with progeroid mice bearing a mutation in the lamin A ( gene. Wild-type animals and progeroid mice that do not overexpress were used as controls. overexpression decreased the lifespan of the progeroid mice and induced the dysregulation of glycolysis, the citric acid cycle and one-carbon metabolism in skeletal muscle, driving dynamic changes in energy metabolism and DNA methylation. This impact on cellular bioenergetics was associated with mitochondrial alterations and affected cellular metabolism, autophagy and protein synthesis through AMPK/mTOR pathways. The data revealed the ability of to promote death in mice with accelerated aging, which supports its putative use as a biomarker of an increased senescent cell burden and for the assessment of the efficacy of interventions aimed at extending healthy aging.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1945-4589
1945-4589
DOI:10.18632/aging.104154